Characteristics and Survival Outcomes of Hepatocellular Carcinoma After the Fontan Operation

By sjmartinez • March 15, 2025

Rosenthal BE, Hoteit MA, Lluri G, Haeffele C, Daugherty T, Krasuski RA, Serfas JD, de Freitas RA, Porlier A, Lubert AM, Wu FM, Valente AM, Krieger EV, Buber Y, Rodriguez FH 3rd, Gaignard S, Saraf A, Hindes M, Earing MG, Lewis MJ, Rosenbaum MS, Zaidi AN, Hopkins K, Bradley EA, Cedars AM, Ko JL, Franklin WJ, Frederickson A, Ginde S, Grewal J, Nyman A, Min J, Schluger C, Rand E, Hilscher M, Rychik J, Kim YY. Characteristics and Survival Outcomes of Hepatocellular Carcinoma After the Fontan Operation. JACC Adv. 2025 Mar 12;4(4):101646. doi: 10.1016/j.jacadv.2025.101646. Epub ahead of print. PMID: 40080923.

Tags: Cardiology/Epi, congenital heart disease, Fontan operation, Fontan-associated liver disease, Hepatocellular carcinoma, Publications, single ventricle

Mitochondrial reactive oxygen species regulate acetyl-CoA flux between cytokine production and fatty acid synthesis in effector T cells

Wu B, Woo JS, Hasiakos S, Pan C, Cokus S, Benincá C, Stiles L, Sun Z, Pellegrini M, Shirihai OS, Lusis AJ, Srikanth S, Gwack[...]

The Reappraisal of Neuropeptide Y as Biomarker and Therapeutic Target in Arrhythmic Disorders

Zaglia T, Ajijola OA. The Reappraisal of Neuropeptide Y as Biomarker and Therapeutic Target in Arrhythmic Disorders. JACC Clin Electrophysiol. 2025 Feb 24:S2405-500X(25)00068-4. doi: 10.1016/j.jacep.2025.01.012.[...]

The Ahmanson/UCLA adult congenital heart disease center, at UCLA, los angeles, USA: The history of a leading ACHD institution and its vision for the future

Aboulhosn J. The Ahmanson/UCLA adult congenital heart disease center, at UCLA, los angeles, USA: The history of a leading ACHD institution and its vision for[...]